Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2015 Apr 22.
Published in final edited form as: Circulation. 2008 Sep 30;118(14 0):S243–S249. doi: 10.1161/CIRCULATIONAHA.107.757526

The Effects of Mitral Regurgitation Alone are Sufficient for Leaflet Remodeling

Elizabeth H Stephens *, Tom C Nguyen ^, Akinobu Itoh ^, Neil B Ingels Jr ^, D Craig Miller ^, K Jane Grande-Allen *
PMCID: PMC4406326  NIHMSID: NIHMS679628  PMID: 18824762

Abstract

Background

Although chronic mitral regurgitation (MR) results in adverse left ventricular remodeling, its effect on the mitral valve leaflets per se is unknown. In a chronic ovine model, we tested whether isolated MR alone was sufficient to remodel the anterior mitral leaflet (AML).

Methods

Twenty-nine sheep were randomized to either control (CTRL, n=11) or experimental (HOLE, n=18) groups. In HOLE, a 2.8–4.8mm diameter hole was punched in the middle scallop of the posterior mitral leaflet to create “pure” MR. At 12 weeks, the AML was analyzed immunohistochemically to assess markers of collagen and elastin synthesis as well as matrix metalloproteinases and proteoglycans. A semi-quantitative grading scale for characteristics such as intensity and delineation of stain between layers was used to quantify differences between HOLE and CTRL specimens across the heterogeneous leaflet structure.

Results

At 12 weeks, MR grade was greater in HOLE vs. CTRL (3.0±0.8 vs. 0.4±0.4, p<0.001). In HOLE AML, saffron-staining collagen (Movat) decreased, consistent with an increase in matrix metalloproteases. Type III collagen expression was increased in the mid-leaflet and free edge and expression of prolyl-4-hydroxylase (indicating collagen synthesis) was increased in the spongiosa layer. The proteoglycan decorin, also involved in collagen fibrillogenesis, was increased compared to CTRL (all p≤0.05).

Conclusions

In HOLE AML, the increased expression of proteins related to collagen synthesis and matrix degradation suggests active matrix turnover. These are the first observations showing that regurgitation alone can stimulate mitral leaflet remodeling. Such leaflet remodeling needs to be considered in reparative surgical techniques.

Keywords: valves, collagen, remodeling, regurgitation, immunohistochemistry

Introduction

Mitral regurgitation (MR) is associated with a number of chronic heart diseases. The prevalence of at least mild severity MR is reported to be approximately 19%,1 and MR in the context of dilated cardiomyopathy (DCM) portends a significantly worse prognosis.24 It has been hypothesized that the MR in DCM is “functional,” i.e., primarily due to left ventricular enlargement and annular dilatation resulting in impaired leaflet coaptation.57 Recent reports of altered leaflet matrix composition in patients with heart failure,8 however, suggests that the leaflet itself is involved in the changes associated with heart failure, perhaps contributing to MR. Indeed, the severity of MR in DCM often increases over time, a phenomenon referred to as “MR begets MR.”9 However, given that many factors contribute to MR in DCM, including ventricular and annular remodeling, ischemic damage, and low pressure volume overload,9, 10 it is unclear which variables drive the worsening regurgitation. The hypothesis of this study was that the altered hemodynamics of regurgitation alone could lead to adverse leaflet remodeling, thereby providing a possible mechanism for “MR begets MR.”9 The goal of this study was to investigate the effect of the isolated hemodynamic variable by creating “pure” primary MR (independent of left ventricular dysfunction) and examine the anterior leaflet for signs of adverse remodeling. The implications of this study would be that of the mitral valve during the course of chronic MR could contribute to worsening MR. Conversely, this causal relationship would also imply that improvements in valve hemodynamics following mitral valve repair surgery could reverse negative remodeling of the valvular extracellular matrix.

In order to test this hypothesis, an ovine animal model of “pure” regurgitation was created by punching a 2.8–4.8 mm hole in the center of the posterior leaflet of the mitral valve. MR was monitored for 12 weeks before the animals were sacrificed and the anterior mitral leaflet (AML) was analyzed to determine if adverse remodeling had occurred. Remodeling was assessed by histological analysis of extracellular matrix (ECM) constituents as well as markers of matrix turnover. ECM not only serves as a structural scaffold, but also plays an active role in critical processes such as tissue differentiation, cell migration, growth factor regulation, mechanical function and disease in various tissues including heart valves.11, 12 In addition, given reports of cell activation and proliferation at the site of valve injury,13 these characteristics were examined as well.

Material and Methods

All animals received humane care in accordance with the guidelines of the US Department of Health and Human Services (NIH Publ. 85-23, Revised 1985). The use of animals in this study was approved by the Stanford Medical Center Laboratory Research Animal Review Committee.

Surgical Protocol

Twenty-nine sheep were randomized to either control (CTRL, n=11) or experimental (HOLE, n=18) groups. Epicardial echocardiography was used to qualitatively grade (0–4) mitral regurgitation (MR) at baseline based on color and width of the regurgitant jet.14 A left thoracotomy and atriotomy were employed to access the mitral valve, and after establishment of cardiopulmonary bypass a 2.8 mm to 4.8 mm hole was created in the central scallop of the posterior mitral leaflet of HOLE animals with an aortic hole puncher (Fig. 1). CTRL animals underwent the exact same operation without the hole-punch. On a weekly basis, a blinded echocardiographer performed transthoracic echocardiography and graded the MR on the basis of color Doppler regurgitant jet extent and width. The MR grades taken at 6 and 12 weeks were combined to determine the “averaged final MR.” The end-diastolic volume index (EDVI) and end-systolic volume index (ESVI) were calculated based on the sum of 3D volumes enclosed by the mitral annular and left ventricular markers, indexed to the body surface area. The full explanation of these calculations and the description of additional measurements performed using this model has been published previously.15

Figure 1.

Figure 1

Intraoperative picture of hole-punch made in posterior leaflet of mitral valve.

Histology and Immunohistochemistry

The anterior leaflet (AML) was isolated and a 5 mm wide strip was cut from annulus to free edge (Fig. 2A). In order to control for heterogeneity in loading and microstructure among different regions of the AML, the strip was taken from the same region in all animals. These cross sections were embedded in paraffin and sectioned to a thickness of five microns. A cross section was also taken from each posterior leaflet (including the region with the hole punch) and subjected to similar studies as those performed here for the AML.16 Those results are reported in a separate manuscript.16 Each sample was stained histologically with Movat pentachrome to demonstrate the general collagen (yellow), elastic fiber (black), and proteoglycan/glycosaminoglycan content (blue) and to distinguish between the different layers of the mitral valve. Picrosirius red staining was performed to examine the collagen content and alignment and infer type of collagen (red=collagen I, yellow/green=reticular collagen III17). Samples were also stained immunohistochemically to demonstrate specific ECM components and enzymes involved in matrix turnover (Table 1), including the proteoglycan decorin (DCN), involved in collagen fibrillogenesis;18 type III collagen (Col III), which tends to be unregulated in remodeling tissues;19 the elastic fiber-related proteins elastin, fibrillin, and lysyl oxidase (LOX, involved in crosslinking both collagen and elastin); two markers of collagen synthesis, prolyl 4-hydroxylase (P4H) and heat shock protein-47 (HSP47); and markers of matrix degradation including the matrix metalloproteases (MMPs)-1, -2, -9, and -13. To determine whether the regurgitation affected the phenotype of the cells within the valve, cell proliferation and valve cell activation were evaluated using antibodies against proliferating cell nuclear antigen (PCNA) and non-muscle myosin (NMM), respectively. In order to limit variability due to staining procedures all leaflets (both HOLE and CTRL) were stained for a given marker together in one batch. A semi-quantitative grading scale from 0 to 4 was used to assess the intensity of staining and the delineation of stain between layers, both throughout the leaflet and in the insertion, annulus, mid-leaflet, and free edge regions (Fig. 3). In addition, “background elastin staining” was defined as the intensity of staining in the fibrosa and spongiosa layers, i.e. between the strongly staining linear fibers found within the atrialis and ventricularis (see circled region in Fig. 3B). All evaluations were performed by a trained individual blinded to the identity of the leaflets.

Figure 2.

Figure 2

A. Diagram showing location from which AML cross sections were taken. B. Photos of fixed CTRL and HOLE valves before sectioning.

Table 1.

Antibodies Used in Immunohistochemistry

Marker Function Dilution
Collagen-related Markers
  Decorin (DCN)* PG associated with tension and collagen fiber formation 1:500
  Collagen III (Col III) Reticular type of collagen 1:100
  Prolyl 4-Hydroxylase (P4H) Hydroxylating enzyme in collagen synthesis 1:200
  Heat shock protein 47 (HSP47) Molecular chaperone in collagen synthesis 1:200
  Lysyl Oxidase (LOX)§ Cross-linking enzyme in collagen synthesis 1:250
Elastic fiber-related
  Elastin Primary component of elastic fibers 1:150
  Fibrillin Elastic fiber component 1:150
  Lysyl Oxidase (LOX)§ Cross-linking enzyme in elastic fiber formation 1:250
Matrix Degradation
  Matrix Metalloprotease (MMP)-1 Enzyme involved in matrix degradation 1:200
  MMP2 Enzyme involved in matrix degradation 1:100
  MMP9 Enzyme involved in matrix degradation 1:100
  MMP13 Enzyme involved in matrix degradation 1:200
Cell Activation/Proliferation
  Proliferating Cell Nuclear Antigen (PCNA) Marker of cell proliferation 1:500
  Non-muscle Myosin (NMM)# Marker of an "activated" cellular phenotype 1:100
*

Gift from Dr. Larry Fisher, NIH;

Abcam, Cambridge, MA;

Chemicon (Temecula, CA);

§

Imgenex (San Diego, CA);

Assay Designs (Ann Arbor, MI);

#

Covance (Berkeley, CA). PG=proteoglycan.

Figure 3.

Figure 3

A. Microstructure of a mitral valve anterior leaflet (originally stained with Movat pentachrome) showing different regions and layers. Thick arrow indicates direction of blood flow from left atrium (LA) to left ventricle (LV). Scale bar represents 2 mm. B. Examples of grading rubrics for the characteristics staining intensity and delineation. For the characteristic delineation, “1” indicates little differentiation in intensity between layers. “4” indicates maximum. The circle indicates the area graded for the characteristic “background elastin intensity.”

Statistical Analysis

Data are presented as mean and standard deviation, unless otherwise noted. Multifactorial analysis of variance was performed using SigmaStat (SPSS, Chicago, IL). When the data was normally distributed, an ANOVA test was used. When the data set was not normally distributed, a rank transform was performed before the ANOVA. In both cases the level of significance was set at 0.05. In a few select cases the p-value for a non-normally distributed data set after rank transformation set was >0.05, while the original ANOVA had a p-value <0.05. In these instances the p-value from the original ANOVA is listed followed by an “R.” In all other cases of non-normalized data sets the p-value from the rank transformed ANOVA is listed. The Holm-Sidak all-pairwise multi-comparison method was used for post-hoc testing. Correlations between factors were calculated using a Spearman rank order correlation test, with a significance level of 0.05.

The authors had full access to the data and take responsibility for its integrity. All authors have read and agree to the manuscript as written.

Results

Throughout the study, the MR grade was greater in HOLE than in CTRL (Fig. 4). At 12 weeks, the grades were 0.4±0.4 vs. 3.0±0.8 for CTRL vs. HOLE, respectively (p<0.001). The regurgitant jet was largely centrally oriented (towards the atrium, Fig. 4B) and did not hit the AML directly. This MR was accompanied by a greater mitral annulus area, primarily due to an increase in the commissure-to-commissure dimension, although there was no evidence of change in the 3D annular shape.15 EDVI and ESVI were both significantly greater in HOLE compared to CTRL at 12 weeks (EDVI: 109.1±30.0 ml/m2 vs. 146.3±30.3 ml/m2 for CTRL vs. HOLE, respectively; ESVI: 81.7±29.5 ml/m2 vs. 106.3±18.7 ml/m2 for CTRL vs. HOLE, respectively, p≤0.004 for both). Levels of circulating biochemical markers such as blood natriuretic peptide were not significantly different between groups. The full details of cardiac changes observed in the HOLE animals have been published previously.15

Figure 4.

Figure 4

A. MR grade of HOLE versus CTRL. B. Sample echo image of regurgitant jet in a HOLE animal.

Numerous differences in the staining of several ECM markers within the AML were found between HOLE and CTRL animals. Cell proliferation, as detected by PCNA staining, tended to be greater in HOLE compared to CTRL (p=0.089), and NMM expression in the fibrosa positively correlated with the average final grade of MR (r=0.225, p<0.027). With respect to the overall amount of collagen, Movat-stained sections showed a significant reduction in saffron-staining collagen in HOLE (p=0.041, Fig. 5). Picrosirius red staining confirmed that Movat saffron-stained regions were composed predominantly of type I, rather than type III, collagen. (When viewed under polarized light the large, linear bundles of type I collagen fibers in picrosirius red-stained tissue appear red, while the small diameter, networked collagen type III fibers appear yellow/green17). HOLE AML showed greater Col III compared to CTRL (p=0.024, Fig. 5), particularly in the mid-leaflet and free edge regions. HOLE AML also showed elevated P4H expression compared to CTRL (p=0.024), which was most notable in the spongiosa layer (p=0.024). DCN expression was greater in HOLE (p=0.022R), which also showed a trend of higher MMP13 intensity compared to CTRL (p=0.081R). MMP9 staining across all regions of HOLE AML was greater than in CTRL AML (p=0.021, Fig. 6A) and MMP1 staining in the fibrosa of the annulus and mid-leaflet regions was greater for HOLE compared to CTRL (p=0.024, Fig. 6B). In these same two regions the background elastin staining (i.e., staining in the spongiosa and fibrosa) was significantly greater in the HOLE AML (p=0.023, Fig. 7). In the insertion region of AML, there was greater staining for Col III in HOLE compared to CTRL (p=0.048) due to an abundance of Col III in the fibrosa layer (p=0.002). The HOLE AML insertion region also showed a trend of greater MMP9 abundance (p=0.070) that was significant in the fibrosa layer (p=0.022).

Figure 5.

Figure 5

Staining intensity of matrix components in HOLE and CTRL animals. *=p<0.05; †=p=0.022R; ‡=p=0.081. Error bars represent the standard error of the mean (SEM).

Figure 6.

Figure 6

A. MMP9 expression in various regions of valve, p=0.021. B. MMP1 staining in the fibrosa layer, p=0.024. Error bars represent SEM.

Figure 7.

Figure 7

Background elastin staining, overall p=0.023. Error bars represent SEM.

Discussion

The principal findings of this study were that HOLE AML exhibited collagen remodeling, demonstrated by a reduction in collagen type I and elevated expression of type III collagen, P4H, DCN, and MMP1. Furthermore, HOLE AML showed evidence of elastic fiber remodeling, including greater MMP9 and elastin expression within the fibrosa and spongiosa layers. Consistent with valvular matrix remodeling, valve cell activation demonstrated by NMM expression was elevated in direct correlation with the average final grade of MR. These results suggest that isolated MR was sufficient to cause mitral valve leaflet remodeling.

Anterior Leaflet Remodeling and Functional Consequences

The finding of collagen remodeling in HOLE AML is demonstrated by the elevation in MMPs, reduction in type I collagen, and greater expression of reticular type III collagen. Additional evidence was provided by the greater abundance of P4H, which is involved in collagen synthesis, and of the proteoglycan DCN, which mediates collagen fibrillogenesis.18 These results are consistent with previous reports of DCN upregulation in human mitral valve prolapse20 and greater amounts of collagen III in rat mitral valves exposed to left ventricular pressure overload.21 Because collagen type III does not have the tensile strength of collagen type I, a shift in the proportions of these collagens may result in decreased valve stiffness and perhaps an increased susceptibility to leaflet prolapse (at least at the 12 week time point).

The greater abundance of MMP9 along with the stronger background elastin staining demonstrated the remodeling of elastic fibers in HOLE AML. MMP9 can degrade elastin, but cannot degrade collagen I and III (the major collagen types in the valve, both substrates for MMP 1, 2, and 13).22 Furthermore, MMP9 expression has been found to colocalize with elastic fiber degradation in valves.23 The observations of cell activation and cell proliferation are also consistent with leaflet remodeling. NMM expression by mature valve cells is associated with valve remodeling and disease,24, 25 and cell proliferation is a well-documented (albeit non-specific) response to valve injury.13

The leaflet remodeling was heterogeneous, but in a manner reflecting the normal varied distribution of collagen and elastin and their distinct roles in leaflet function. For example, stronger background elastin staining was evident in the annulus and mid-leaflet, regions where elastin is normally most abundant, albeit in the atrialis and ventricularis as opposed to the fibrosa and spongiosa. Given that elastic fibers govern the elastic recoil of the tissue, this greater abundance of “background” elastin may indicate altered mechanical loading of the AML. With respect to collagen remodeling, the stronger MMP1 staining was specifically found in the fibrosa of the mid-leaflet and annulus, whereas the stronger type III collagen staining was predominantly found in the mid-leaflet and free edge. Type I collagen is normally most abundant in the fibrosa layer within the annulus and mid-leaflet regions, and is critical to the leaflet’s tensile strength. Given the specificity of MMP1 for collagen type I,26 it is logical that MMP1 expression would be stronger in the fibrosa layer of these regions. It may be that the nature of the regurgitant jet and the altered coaptation patterns caused increased tension on the free edge and mid-leaflet regions, which could explain the greater abundance of type III collagen in those regions. It is also interesting to note that the insertion region (annular ring) of HOLE AML showed greater abundance of Col III and MMP9.

We speculate that the MR resulting from the hole-punch led to altered stress on HOLE AML, which led to altered collagen turnover throughout the various leaflet regions. Functionally, in the mid-leaflet region this altered collagen content would reduce tensile strength, leading to leaflet prolapse that could worsen MR. Altered collagen turnover in the insertion region (part of the mitral fibrous annulus) would result in decreased tensile strength of this region and lead to annular dilation, as evident in HOLE. This annular dilation would also then worsen MR.5 Although less annular dilation occurs in the anterior as opposed to the posterior mitral annulus in DCM,27 anterior annular dilation has been documented in both animal models27 and human cases of DCM.28

Potential Mechanism for Observed Changes

The proposed mechanism for the observed dysfunction in the HOLE animals involves interrelated changes at three hierarchical levels: cardiac, valve/hemodynamic, and leaflet ECM/microstructure. Cardiac changes include annular dilation caused by altered strain patterns in the left ventricle due to the HOLE-induced MR; this annular dilation would exacerbate MR.5 Considering the level of the valve, computer modeling has shown that during normal coaptation, the AML shares the burden of stress with the posterior leaflet.5 With regurgitation and annular dilation, however, coaptation is reduced, forcing the AML to bear greater stress.5 Indeed, leaflets under increased stress show increased collagen synthesis.29 At the level of the ECM and individual valve layers, the collagen type I-rich fibrosa is responsible for the leaflet’s tensile strength. Based on the greater staining for non-muscle myosin (a myofibroblastic phenotypic marker) in the fibrosa and the positive correlation between this staining and the average final MR, it appears that the fibrosa is experiencing increased stress related to MR. It also appears that collagen remodeling is occurring with type I collagen being replaced by flexible reticular type III collagen. Although this remodeling was likely initiated in reaction to the altered stresses, the altered collagen proportions could reduce the tensile strength of the AML and worsen MR.

Pathological versus Adaptive Leaflet Remodeling

While this study provides the first evidence to date that regurgitation alone is sufficient to cause leaflet remodeling, it is difficult to say whether or not these changes in the AML should be considered pathological (detrimental) or adaptive (advantageous). From a clinical and pathological perspective, these changes would seem to be detrimental. Certainly, a decrease in the amount of type I collagen would make the leaflet more prone to prolapse, but it is not clear whether other changes such as increased expression of P4H and similar markers should be considered detrimental. Increased DCN expression has been reported in prolapsed mitral valves,20 but it is not clear whether the changes in DCN expression were causing the prolapse or attempting to counteract prolapse. It is also important to note that in this study only a single time-point was examined. Therefore, the reduction in collagen may have been a transient event in a process of adaptive remodeling to restore leaflet integrity that would be followed by the production of new collagen (as suggested by the greater expression of P4H). Other findings, however, suggest that this remodeling is “pathological.” Elevated MMP9 expression has been associated with a number of valve pathologies, including non-rheumatic aortic stenosis.30 Increases in other MMPs have also been reported in diseased valves including myxomatous mitral valves24, 31 and stenotic aortic valves.23 Myxomatous mitral valves also demonstrate a higher ratio of type III to type I collagen, as suggested by the results of this study.19

Potential Mechanism for “MR begets MR”

This unique animal model created isolated regurgitation to investigate how the valve was affected by low pressure volume overload, and showed that regurgitation alone can initiate leaflet remodeling. Several animal models of chronic MR have been created previously, but these have all involved the confounding effects of ventricular ischemia and remodeling and/or created regurgitation using high pressure volume overload,32 which is significantly different than the hemodynamics seen in clinical MR.33 For instance, the severance of chordae has been shown to alter left ventricular geometry and strain patterns and cause global systolic dysfunction.34 Many cases of chronic MR involve factors other than altered hemodynamics that contribute to increasing regurgitation. A paradigm often used to account for chronically increasing MR is that ventricular dilation, which frequently accompanies chronic MR, increases ventricular wall stress10 and impairs left ventricular ejection performance, which then augments regurgitation.10 Others see MR as principally due to annular dilatation that results in impaired leaflet coaptation.57 In these views the MR is “functional,” a result of changes in left ventricular structure and function. However, the findings of the present study suggest that MR itself could be an independent factor contributing to chronically increasing MR via leaflet remodeling.

These results have implications for a number of clinical conditions. In this paper we have shown that a primarily hemodynamic insult results in secondary organic changes with functional consequences. Hemodynamics may similarly affect very different conditions, such as myxomatous mitral valves. Leaflets that have undergone organic changes (i.e., myxomatous degeneration) may be sensitive to changes in loading that could further deteriorate cardiac function. Likewise, myxomatous valves in which regurgitation has been surgically corrected would experience improved hemodynamics, and may undergo positive remodeling. Overall, changes in left ventricular and annular structure and function, organic changes in the mitral valve leaflets, and cardiac and valvular hemodynamic changes are interrelated factors that distinctly influence one another and trigger further cardiac dysfunction.

Limitations

Caution should be exercised in extrapolating the results of this ovine study to human hearts. One of the most important limitations was the duration of MR. While in patients MR progresses slowly over the course of years, these animals had isolated MR for only 12 weeks. Regardless, significant differences were found even within this short time period. Another limitation was that increasing MR was not detected over the 12-week period. This finding was likely due to the short time course and the decrease in the posterior leaflet’s hole size as it healed (analysis of the posterior leaflet was reported separately16). Furthermore, although the changes in HOLE were primarily driven by MR, there were secondary changes in left ventricular dimensions, such as annular dilation, that could have affected leaflet composition. However, all of the effects on leaflet composition were either directly or indirectly caused by MR. Another limitation was the narrow range of MR in the HOLE animals. A wider range of MR, combined with more specific hemodynamic measurements, would have enabled detection of more direct correlations between hemodynamics and AML compositional changes.

Limitations in the leaflet analysis included the subjective nature of histological grading. To make this process more objective, a grading rubric was used for each characteristic, the grader was blinded to leaflet identity, and all leaflets stained for a given marker were evaluated at the same time. Another limitation was that the surgical and histological analyses were performed at different institutions, so it was not possible to perform materials testing on these tissues or to link material properties directly to matrix changes. In the future, it will be important to analyze the remodeling and material behavior of other parts of the mitral valve, including the fibrous trigones, the chordae, and the other regions of the AML, because loading patterns across the valve are very heterogeneous.

Conclusion

Using a novel animal model of isolated mitral regurgitation, this study provides the first evidence that regurgitation alone can result in leaflet remodeling. The HOLE AML showed elevated expression of MMPs and reduced expression of type I collagen, along with greater abundance of P4H (a marker of active collagen synthesis), DCN (a proteoglycan involved in collagen fibrillogenesis), and type III collagen. Taken together, these changes suggest an increase in matrix degradation and in collagen synthesis, particularly type III collagen synthesis. Furthermore, greater abundance of elastin in the spongiosa and fibrosa layers of the HOLE AML and higher levels of the elastin-degrading MMP9 suggest that elastin remodeling is also occurring.

Acknowledgements

Thanks to the members of the Grande-Allen laboratory, especially Joshua Carroll, Luis Lazaro, and Jack Blazejewski along with the statistical expertise of Dr. Scott Baggett.

Funding

Funding comes in part by Grant 0502342 from the National Science Foundation (KJGA), a Hertz Graduate Fellowship (EHS), Grants HL-29589 and HL-67025 from the National Heart Lung and Blood Institute (DCM), the McConnell Cardiovascular Surgical Research Fellowship program (TCN, AI), Thoracic Society Foundation Research Education Fellowship (TCN), and Uehara Memorial Foundation Research Fellowship, Japan (AI).

Footnotes

Conflict of Interest Disclosures

None other than the funding sources listed above.

References

  • 1.Singh J, Evans J, Levy D, Larson M, Freed LA, Fuller D, Lehman B, Benjamin E. Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation (the Framingham Heart Study) Am J Cardiol. 1999;83(6):897–902. doi: 10.1016/s0002-9149(98)01064-9. [DOI] [PubMed] [Google Scholar]
  • 2.Blondheim D, Jacobs L, Kotler M, Costacurta G, Parry W. Dilated cardiomyopathy with mitral regurgitation: decreased survival despite a low frequency of left ventricular thrombus. Am Heart J. 1991;122(3 Pt 1):763–771. doi: 10.1016/0002-8703(91)90523-k. [DOI] [PubMed] [Google Scholar]
  • 3.Junker A, Thayssen P, Nielsen B, Andersen P. The hemodynamic and prognostic significance of echo-Doppler-proven mitral regurgitation in patients with dilated cardiomyopathy. Cardiology. 1993;83(1–2):14–20. doi: 10.1159/000175942. [DOI] [PubMed] [Google Scholar]
  • 4.Romeo F, Pelliccia F, Cianfrocca C, Gallo P, Barilla F, Cristofani R, Reale A. Determinants of end-stage idiopathic dilated cardiomyopathy: a multivariate analysis of 104 patients. Clin Cardiol. 1989;12(7):387–392. doi: 10.1002/clc.4960120708. [DOI] [PubMed] [Google Scholar]
  • 5.Kunzelman KS, Reimink M, Cochran RP. Annular dilatation increases stress in the mitral valve and delays coaptation: a finite element computer model. Cardiovasc Surg. 1997;5(4):427–434. doi: 10.1016/s0967-2109(97)00045-8. [DOI] [PubMed] [Google Scholar]
  • 6.Donal E, Levy F, Tribouilloy C. Chronic ischemic mitral regurgitation. J Heart Valve Dis. 2006;15(2):149–157. [PubMed] [Google Scholar]
  • 7.Bolling S. Mitral valve reconstruction in the patient with heart failure. Heart Fail Rev. 2001;6(3):177–185. doi: 10.1023/a:1011421014480. [DOI] [PubMed] [Google Scholar]
  • 8.Grande-Allen KJ, Borowski AG, Troughton RW, Houghtaling PL, Dipaola NR, Moravec CS, Vesely I, Griffin BP. Apparently normal mitral valves in patients with heart failure demonstrate biochemical and structural derangements: an extracellular matrix and echocardiographic study. J Am Coll Cardiol. 2005;45(1):54–61. doi: 10.1016/j.jacc.2004.06.079. [DOI] [PubMed] [Google Scholar]
  • 9.Borger M, Alam A, Murphy P, Doenst T, David T. Chronic ischemic mitral regurgitation: repair, replace or rethink? Annals Thorac Surg. 2006;81(3):1153–1161. doi: 10.1016/j.athoracsur.2005.08.080. [DOI] [PubMed] [Google Scholar]
  • 10.Carabello BA. Ischemic mitral regurgitation and ventricular remodeling. J Am Coll Cardiol. 2004;43(3):384–385. doi: 10.1016/j.jacc.2003.11.009. [DOI] [PubMed] [Google Scholar]
  • 11.Butcher J, McQuinn T, Sedmera D, Turner D, Markwald R. Transitions in early embryonic atrioventricular valvular function correspond with changes in cushion biomechanics that are predictable by tissue composition. Circ Res. 2007;100(10):1503–1511. doi: 10.1161/CIRCRESAHA.107.148684. [DOI] [PubMed] [Google Scholar]
  • 12.Grande-Allen K, Griffin B, Ratliff N, Cosgrove D, Vesely I. Glycosaminoglycan profiles of myxomatous mitral leaflets and chordae parallel the severity of mechanical alterations. J Am Coll Cardiol. 2003;42(2):271–277. doi: 10.1016/s0735-1097(03)00626-0. [DOI] [PubMed] [Google Scholar]
  • 13.Tamura K, Jones M, Yamada I, Ferrans VJ. Wound healing in the mitral valve. J Heart Valve Dis. 2000;9(1):53–63. [PubMed] [Google Scholar]
  • 14.Helmcke F, Nanda N, Hsiung M, Soto B, Adey C, Goyal R, Gatewood R., Jr Color Doppler assessment of mitral regurgitation with orthogonal planes. Circulation. 1987;75(1):175–183. doi: 10.1161/01.cir.75.1.175. [DOI] [PubMed] [Google Scholar]
  • 15.Nguyen T, Itoh A, Carlhall C, Bothe W, Timek T, Ennis D, Oakes R, Liang D, Daughters G, Ingels N, Miller D. The effect of pure mitral regurgitation on mitral annular geometry and saddle-shape. J Thorac Cardiovasc Surg. 2008 doi: 10.1016/j.jtcvs.2007.12.087. in press. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Stephens E, Nguyen T, Blazejewski J, Itoh A, Miller D, Grande-Allen K. Wound healing in ovine mitral valves involves significant leaflet remodeling. Cardiovasc Pathol. 2008 submitted. [Google Scholar]
  • 17.Zhang H, Sun L, Wang W, Ma X. Quantitative analysis of fibrosis formation on the microcapsule surface with the use of picro-sirius red staining, polarized light microscopy, and digital image analysis. J Biomed Mater Res. 2006;76A:120–125. doi: 10.1002/jbm.a.30491. [DOI] [PubMed] [Google Scholar]
  • 18.Kinsella MG, Bressler SL, Wight TN. The regulated synthesis of versican, decorin, and biglycan: extracellular matrix proteoglycans that influence cellular phenotype. Crit Rev Eukaryot Gene Expr. 2004;14(3):203–234. doi: 10.1615/critreveukaryotgeneexpr.v14.i3.40. [DOI] [PubMed] [Google Scholar]
  • 19.Lis Y, Burleigh MC, Parker DJ, Child AH, Hogg J, Davies MJ. Biochemical characterization of individual normal, floppy and rheumatic human mitral valves. Biochem J. 1987;244(3):597–603. doi: 10.1042/bj2440597. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Radermecker M, Limet R, Lapiere C, Nusgens B. Increased mRNA expression of decorin in the prolapsing posterior leaflet of the mitral valve. Interact Cardiovasc Thorac Surg. 2003;2:389–394. doi: 10.1016/S1569-9293(03)00107-5. [DOI] [PubMed] [Google Scholar]
  • 21.Willems I, Havenith M, Smits J, Daemen M. Structural alterations in heart valves during left ventricular pressure overload in the rat. Lab Invest. 1994;71(1):127–133. [PubMed] [Google Scholar]
  • 22.Steffensen B, Häkkinen L, Larjava H. Proteolytic events of wound-healing--coordinated interactions among matrix metalloproteinases (MMPs), integrins, and extracellular matrix molecules. Crit Rev Oral Biol Med. 2001;12(5):373–398. doi: 10.1177/10454411010120050201. [DOI] [PubMed] [Google Scholar]
  • 23.Koullias GJ, Korkolis DP, Ravichandran P, Psyrri A, Hatzaras I, Elefteriades JA. Tissue microarray detection of matrix metalloproteinases, in diseased tricuspid and bicuspid aortic valves with or without pathology of the ascending aorta. Eur J Cardiothorac Surg. 2004;26(6):1098–1103. doi: 10.1016/j.ejcts.2004.07.050. [DOI] [PubMed] [Google Scholar]
  • 24.Rabkin E, Aikawa M, Stone JR, Fukumoto Y, Libby P, Schoen FJ. Activated interstitial myofibroblasts express catabolic enzymes and mediate matrix remodeling in myxomatous heart valves. Circulation. 2001;104(21):2525–2532. doi: 10.1161/hc4601.099489. [DOI] [PubMed] [Google Scholar]
  • 25.Rabkin-Aikawa E, Farber M, Aikawa M, Schoen FJ. Dynamic and reversible changes of interstitial cell phenotype during remodeling of cardiac valves. J Heart Valve Dis. 2004;13(5):841–847. [PubMed] [Google Scholar]
  • 26.Keller F, Leutert G. [Age dependence of collagen structures of the human heart] Z Gerontol. 1994;27(3):186–193. [PubMed] [Google Scholar]
  • 27.Timek T, Dagum P, Lai D, Liang D, Daughters G, Tibayan F, Ingels N, Miller D. Tachycardia-induced cardiomyopathy in the ovine heart: Mitral annular dynamic three-dimensional geometry. J Thorac Cardiovasc Surg. 2003;125(2):315–324. doi: 10.1067/mtc.2003.80. [DOI] [PubMed] [Google Scholar]
  • 28.Hueb A, Jatene F, Moreira L, Pomerantzeff P, Kallás E, de Oliveira S. Ventricular remodeling and mitral valve modifications in dilated cardiomyopathy: new insights from anatomic study. J Thorac Cardiovasc Surg. 2002;124(6):1216–1224. doi: 10.1067/mtc.2002.125342. [DOI] [PubMed] [Google Scholar]
  • 29.Quick D, Kunzelman K, Kneebone J, Cochran R. Collagen synthesis is upregulated in mitral valves subjected to altered stress. ASAIO J. 1997;43(3):181–186. [PubMed] [Google Scholar]
  • 30.Kaden JJ, Vocke DC, Fischer CS, Grobholz R, Brueckmann M, Vahl CF, Hagl S, Haase KK, Dempfle CE, Borggrefe M. Expression and activity of matrix metalloproteinase-2 in calcific aortic stenosis. Z Kardiol. 2004;93(2):124–130. doi: 10.1007/s00392-004-1021-0. [DOI] [PubMed] [Google Scholar]
  • 31.Togashi M, Tamura K, Nitta T, Ishizaki M, Sugisaki Y, Fukuda Y. Role of matrix metalloproteinases and their tissue inhibitor of metalloproteinases in myxomatous change of cardiac floppy valves. Pathol Int. 2007;57(5):251–259. doi: 10.1111/j.1440-1827.2007.02096.x. [DOI] [PubMed] [Google Scholar]
  • 32.Carabello BA. Models of volume overload hypertrophy. J Card Fail. 1996;2(1):55–64. doi: 10.1016/s1071-9164(96)80010-8. [DOI] [PubMed] [Google Scholar]
  • 33.Bursi F, Enriquez-Sarano M, Jacobsen S, Roger V. Mitral regurgitation after myocardial infarction: a review. Am J Med. 2006;119(2):103–112. doi: 10.1016/j.amjmed.2005.08.025. [DOI] [PubMed] [Google Scholar]
  • 34.Rodriguez F, Langer F, Harrington K, Tibayan F, Zasio M, Cheng A, Liang D, Daughters G, Jr, Covell JW, Criscione J, Ingels N, Jr, Miller D. Importance of mitral valve second-order chordae for left ventricular geometry, wall thickening mechanics, and global systolic function. Circulation. 2004;110(suppl II):II-115–II-122. doi: 10.1161/01.CIR.0000138580.57971.b4. [DOI] [PubMed] [Google Scholar]

RESOURCES